Kala Bio
(NASDAQ) KALA
Kala Bio Financials at a Glance
Market Cap
$182.27M
Revenue (TTM)
$254.00K
Net Income (TTM)
$35.84M
EPS (TTM)
$-5.94
P/E Ratio
-0.03
Dividend
$0.00
Beta (Volatility)
0.91 (Low)
Dividend
$0.00
Beta (Volatility)
0.91 (Low)
Price
$0.20
Volume
2,580
Open
$0.21
Price
$0.20
Volume
2,580
Open
$0.21
Previous Close
$0.20
Daily Range
$0.20 - $0.22
52-Week Range
$0.20 - $20.60
Dividend
$0.00
Beta (Volatility)
0.91 (Low)
Price
$0.20
Volume
2,580
Open
$0.21
Previous Close
$0.20
Daily Range
$0.20 - $0.22
52-Week Range
$0.20 - $20.60
KALA News
KALA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Kala Bio
Industry
Biotechnology
Sector
Health CareEmployees
38
CEO
Todd Bazemore
Website
www.kalarx.comHeadquarters
Arlington, MA 02476, US
KALA Financials
Key Financial Metrics (TTM)
Gross Margin
-3%
Operating Margin
-151%
Net Income Margin
-141%
Return on Equity
-708%
Return on Capital
5%
Return on Assets
-1%
Earnings Yield
-33.33%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$182.27M
Shares Outstanding
911.33M
Volume
2.58K
Short Interest
0.00%
Avg. Volume
7.00M
Financials (TTM)
Gross Profit
$259.00K
Operating Income
$40.98M
EBITDA
$40.98M
Operating Cash Flow
$29.38M
Capital Expenditure
$208.00K
Free Cash Flow
$29.59M
Cash & ST Invst.
$51.18M
Total Debt
$32.25M
Kala Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
$182.27M
N/A
Market Cap/Employee
$4.80M
N/A
Employees
38
N/A
Net Income
$7.56M
+15.5%
EBITDA
$6.47M
+12.6%
Quarterly Fundamentals
Net Cash
$9.96M
-181.9%
Accounts Receivable
$8.00K
N/A
Inventory
$0.00
N/A
Long Term Debt
$2.22M
-88.1%
Short Term Debt
$28.83M
+57.2%
Return on Assets
-1.43%
N/A
Return on Invested Capital
5.06%
N/A
Free Cash Flow
$10.86M
-132.3%
Operating Cash Flow
$10.88M
-130.2%